Recognizing Parkinson Disease and Developing Better Treatments
January 2nd 2019The associate professor of neurology and the director of clinical trials at the University of Florida’s Center for Movement Disorders and Neurorestoration spoke about what’s being developed in the Parkinson disease pipeline.
Recognizing Tardive Dyskinesia and Collaborating In Its Management
December 28th 2018The associate professor of neurology and the director of clinical trials at the University of Florida’s Center for Movement Disorders and Neurorestoration spoke about addressing the complex relationship between caregivers in treating tardive dyskinesia.
Investigators Unlock New Targets in Obstructive Sleep Apnea
December 21st 2018The principal research scientist at Neuroscience Research Australia and an associate professor of medicine at the University of New South Wales provided more insight into the latest knowledge regarding sleep apnea phenotyping and its role in the development of targeted pharmacotherapies.
Bryostatin Shows Some Effect in Moderate to Severe Alzheimer Disease
December 21st 2018Although the therapy did not achieve significance for the primary end point in the full data set, a pre-specified exploratory analysis implemented in a post-hoc framework did provide evidence of significant benefit for the 20-μg dose.